Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models

/in , , /by

Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering WALTHAM, Mass. —  Revvity, Inc. (NYSE: RVTY) today announced a collaboration with Eli Lilly and Company (Lilly) that expands access to Lilly’s high-quality predictive models by making Lilly TuneLab available through the Revvity Signals platform. The collaboration builds on Revvity’s recently introduced Signals XyntheticaTM offering, creating […]

Read more →

Illumina and PREMIA partner to expand clinical access to CGP in Asia

/in , /by

TAIPEI — Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer clinical-genomic screening network, today announced the formation of a strategic partnership that will expand access to comprehensive genomic profiling (CGP) for all eligible oncology patients across the Chang Gung Memorial Hospital (CGMH) system. This partnership also aims to support the […]

Read more →

Benchling and Lilly TuneLab Partner to Democratize Access to AI Models for Scientists Everywhere

/in , , /by

Collaboration makes AI models trained on over $1 billion in Lilly research data accessible directly in scientists’ workflows SAN FRANCISCO — Benchling, the platform for scientific progress, today announced a strategic collaboration with Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform created by Eli Lilly and Company (Lilly) to provide access to models trained on decades […]

Read more →

L7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale

/in , /by

Collaboration combines AI-ready data platforms with delivery certainty to help life sciences and food companies move faster, from strategy to measurable outcomes. AUSTIN, TX and MINNEAPOLIS, MN – L7 Informatics, Inc., and Turnberry Solutions, Inc. today announced the completion of a strategic Teaming Agreement, establishing a formal collaboration to jointly pursue enterprise digital transformation initiatives […]

Read more →

Factorial Biotechnologies and Honeycomb Biotechnologies Partner to Deliver High-Throughput, Instrument-Free Single-Cell DNA Sequencing

/in , , , , /by

New partnership combines Factorial’s in-cell library preparation chemistry with Honeycomb’s HIVE™ platform to enable scalable single-cell WGS workflow with processing capacity up to 1 million cells per day. SAN CARLOS, Calif., and WALTHAM, Mass. — Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced […]

Read more →

Arrayjet Opens First US Printing Suite in Bend, Oregon, in Strategic Collaboration with Grace Bio Labs

/in , , /by

BEND, OREGON – SCOTLAND, UK — Arrayjet, an inventor and leading provider of high-speed inkjet microarray technology, is pleased to announce the opening of its first US laboratory in Bend, Oregon. The new Arrayjet Printing Suite, located within Grace Bio Labs, marks a significant step in strengthening support for its North American customers and partners. “This […]

Read more →

TheWell Bioscience and PeptiGrowth Enter into Marketing Collaboration Agreement to Advance Next-Generation Cell Culture Solutions

/in , , , /by

MONMOUTH JUNCTION, N.J. and TOKYO — TheWell Bioscience Inc., a biotechnology company pioneering next-generation animal-free biofunctional hydrogels, and PeptiGrowth Inc., a leader in innovative synthetic peptide growth factors, today announced that the two companies have entered into a Marketing Collaboration Agreement to jointly promote cutting-edge solutions for stem cell culture, organoid development, and cell therapy manufacturing. TheWell Bioscience manufactures VitroGel®, an […]

Read more →

SOPHiA GENETICS and MD Anderson Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology

/in , , , /by

BOSTON and HOUSTON — SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration that unites SOPHiA GENETICS’ AI-powered analytics with MD Anderson’s clinical and scientific expertise to accelerate data-driven cancer care through new tools that can accurately analyze, interpret and translate […]

Read more →

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

/in , /by

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling Brisbane, CA – CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced […]

Read more →

Singleron and DKSH Announce Strategic Partnership to Expand Access to Single Cell Multi-Omics Solutions in Australia and New Zealand

/in , , , /by

Singapore – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of advanced life science products in Australia and New Zealand. With this partnership, DKSH will become the exclusive distributor of Singleron’s innovative single cell multi-omics solutions in Australia and New Zealand. DKSH will provide Singleron’s comprehensive […]

Read more →